GRAIL Reports First Quarter 2025 Financial Results

Q1 U.S. Galleri Revenue Grew 22% Year-Over-Year to $28.7 MillionGRAIL Announces Positive Top-Line Results From the Prevalent Screening Round of the NHS-Galleri TrialCash Position of $677.9 Million Provides Runway Into 2028MENLO PARK, Calif., May 13, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today reported business and financial results for the first quarter 2025.Total revenue in the first quarter was $31.8 million, rep ...